B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.

Avihingsanon A, Leong CL, Hung CC, Kiertiburanakul S, Lee MP, D'Antoni ML, Madera S, Wang H, Hindman JT, Li T

Open source

DOI
10.1186/s12981-026-00891-4
Published
2026 Jul 16
Container
AIDS research and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12981-026-00891-4,
  title = {B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.},
  author = {Avihingsanon A and Leong CL and Hung CC and Kiertiburanakul S and Lee MP and D'Antoni ML and Madera S and Wang H and Hindman JT and Li T},
  year = {2026},
  journal = {AIDS research and therapy},
  doi = {10.1186/s12981-026-00891-4},
  url = {https://doi.org/10.1186/s12981-026-00891-4}
}

RIS

TY  - JOUR
TI  - B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.
AU  - Avihingsanon A
AU  - Leong CL
AU  - Hung CC
AU  - Kiertiburanakul S
AU  - Lee MP
AU  - D'Antoni ML
AU  - Madera S
AU  - Wang H
AU  - Hindman JT
AU  - Li T
PY  - 2026
JO  - AIDS research and therapy
DO  - 10.1186/s12981-026-00891-4
UR  - https://doi.org/10.1186/s12981-026-00891-4
ER  - 

APA

A, A., CL, L., CC, H., S, K., MP, L., ML, D., S, M., H, W., JT, H., & T, L. (2026). B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.. AIDS research and therapy. https://doi.org/10.1186/s12981-026-00891-4

Source records